ArticleDiscover oncology2025

Radiotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion chemotherapy of RALOX versus FOLFOX for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score-matching cohort study.

Hao-Yang Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.